Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Kirstein

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 18, 1981
Determination of the cholesterol content of high density lipoprotein subfractions HDL2 and HDL3, without contamination of Lp(a), in human plasmaP Kirstein, K Carlson
Atherosclerosis|September 1, 1984
Relationship between lipoproteins including HDL subfractions and the intravenous fat tolerance testS Rössner, P Kirstein
The Journal of Experimental Medicine|February 1, 1977
T-cell-mediated concomitant immunity to syngeneic tumors. I. Activated macrophages as the expressors of nonspecific immunity to unrelated tumors and bacterial parasitesR J North, D P Kirstein
The Journal of Experimental Medicine|December 1, 1978
The immunological basis of endotoxin-induced tumor regression. Requirement for T-cell-mediated immunityM J Berendt, R J North, D P Kirstein
The Journal of Experimental Medicine|December 1, 1978
The immunological basis of endotoxin-induced tumor regression. Requirement for a pre-existing state of concomitant anti-tumor immunityM J Berendt, R J North, D P Kirstein
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 2, 1981
Changes in high density lipoprotein subfractions and other lipoproteins by exerciseE R Nye, K Carlson, P Kirstein, et al.
The Journal of Experimental Medicine|March 1, 1976
Subversion of host defense mechanisms by murine tumors. I. A circulating factor that suppresses macrophage-mediated resistance to infectionR J North, D P Kirstein, R L Tuttle
The Journal of Experimental Medicine|March 1, 1976
Subversion of host defense mechanisms by murine tumors. II. Counter-influence of concomitant antitumor immunityR J North, D P Kirstein, R L Tuttle
Atherosclerosis|August 1, 1980
Antiaggregatory, physiological and clinical effects of ticlopidine in subjects with peripheral atherosclerosisP Kirstein, T Jogestrand, H Johnsson, et al.
Journal of Internal Medicine|August 1, 1990
Effects of nicotinic acid on serum cholesterol concentrations of high density lipoprotein subfractions HDL2 and HDL3 in hyperlipoproteinaemiaG Wahlberg, G Walldius, A G Olsson, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 18, 1981
Determination of the cholesterol content of high density lipoprotein subfractions HDL2 and HDL3, without contamination of Lp(a), in human plasmaP Kirstein, K Carlson
Atherosclerosis|September 1, 1984
Relationship between lipoproteins including HDL subfractions and the intravenous fat tolerance testS Rössner, P Kirstein
The Journal of Experimental Medicine|February 1, 1977
T-cell-mediated concomitant immunity to syngeneic tumors. I. Activated macrophages as the expressors of nonspecific immunity to unrelated tumors and bacterial parasitesR J North, D P Kirstein
The Journal of Experimental Medicine|December 1, 1978
The immunological basis of endotoxin-induced tumor regression. Requirement for T-cell-mediated immunityM J Berendt, R J North, D P Kirstein
The Journal of Experimental Medicine|December 1, 1978
The immunological basis of endotoxin-induced tumor regression. Requirement for a pre-existing state of concomitant anti-tumor immunityM J Berendt, R J North, D P Kirstein
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 2, 1981
Changes in high density lipoprotein subfractions and other lipoproteins by exerciseE R Nye, K Carlson, P Kirstein, et al.
The Journal of Experimental Medicine|March 1, 1976
Subversion of host defense mechanisms by murine tumors. I. A circulating factor that suppresses macrophage-mediated resistance to infectionR J North, D P Kirstein, R L Tuttle
The Journal of Experimental Medicine|March 1, 1976
Subversion of host defense mechanisms by murine tumors. II. Counter-influence of concomitant antitumor immunityR J North, D P Kirstein, R L Tuttle
Atherosclerosis|August 1, 1980
Antiaggregatory, physiological and clinical effects of ticlopidine in subjects with peripheral atherosclerosisP Kirstein, T Jogestrand, H Johnsson, et al.
Journal of Internal Medicine|August 1, 1990
Effects of nicotinic acid on serum cholesterol concentrations of high density lipoprotein subfractions HDL2 and HDL3 in hyperlipoproteinaemiaG Wahlberg, G Walldius, A G Olsson, et al.
Pageof 2